Anzeige
Mehr »
Login
Montag, 06.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
17 Leser
Artikel bewerten:
(0)

Genetic Testing - Global Strategic Business Report

DUBLIN, Sept. 10, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Genetic Testing - Global Strategic Business Report" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

This report analyzes the worldwide markets for Genetic Testing in US$ Million by the following Product Segments: Prenatal and Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive Testing.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets.

Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 73 companies including many key and niche players such as:

  • Abbott Laboratories
  • AutoGenomics, Inc.
  • BioRad Laboratories
  • ELITech Group S.P.A
  • PerkinElmer, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
  • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
  • Prenatal Diagnosis and Newborn Genetic Testing
  • Pharmacogenetics/Pharmacogenomics
  • Predictive Testing

II. EXECUTIVE SUMMARY
1. GLOBAL MARKET OVERVIEW
2. SEGMENTAL REVIEW
3. MARKET TRENDS
4. MOLECULAR DIAGNOSTICS MARKET AN INSIGHT
5. PRODUCT OVERVIEW
6. PRODUCT LAUNCHES/INNOVATIONS
7. RECENT INDUSTRY ACTIVITY
8. FOCUS ON SELECT GLOBAL PLAYERS

  • Abbott Laboratories (US)
  • Abbott Molecular, Inc. (US)
  • AutoGenomics, Inc. (US)
  • BioRad Laboratories (US)
  • ELITech Group S.P.A. (France)
  • PerkinElmer, Inc. (US)
  • Quest Diagnostics, Inc. (US)
  • Roche Diagnostics Corp. (Switzerland)
  • Roche Molecular Diagnostics, Inc. (US)
  • Thermo Fisher Scientific (US)
  • Transgenomic, Inc. (US)

9. GLOBAL MARKET PERSPECTIVE

III. MARKET
1. THE UNITED STATES
2. CANADA
3. JAPAN
4. EUROPE
5. ASIA-PACIFIC
6. REST OF WORLD

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 73 (including Divisions/Subsidiaries 79)

  • The United States (56)
  • Canada (3)
  • Europe (18)
  • France (2)
  • Germany (3)
  • The United Kingdom (3)
  • Spain (1)
  • Rest of Europe (9)
  • Asia-Pacific (Excluding Japan) (2)

For more information visit http://www.researchandmarkets.com/research/64wbhh/genetic_testing

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.